The Search for Reliable Biomarkers of Disease in Multiple Chemical Sensitivity and Other Environmental Intolerances
Open Access
- 1 July 2011
- journal article
- review article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 8 (7), 2770-2797
- https://doi.org/10.3390/ijerph8072770
Abstract
Whilst facing a worldwide fast increase of food and environmental allergies, the medical community is also confronted with another inhomogeneous group of environment-associated disabling conditions, including multiple chemical sensitivity (MCS), fibromyalgia, chronic fatigue syndrome, electric hypersensitivity, amalgam disease and others. These share the features of poly-symptomatic multi-organ cutaneous and systemic manifestations, with postulated inherited/acquired impaired metabolism of chemical/physical/nutritional xenobiotics, triggering adverse reactions at exposure levels far below toxicologically-relevant values, often in the absence of clear-cut allergologic and/or immunologic involvement. Due to the lack of proven pathogenic mechanisms generating measurable disease biomarkers, these environmental hypersensitivities are generally ignored by sanitary and social systems, as psychogenic or “medically unexplained symptoms”. The uncontrolled application of diagnostic and treatment protocols not corresponding to acceptable levels of validation, safety, and clinical efficacy, to a steadily increasing number of patients demanding assistance, occurs in many countries in the absence of evidence-based guidelines. Here we revise available information supporting the organic nature of these clinical conditions. Following intense research on gene polymorphisms of phase I/II detoxification enzyme genes, so far statistically inconclusive, epigenetic and metabolic factors are under investigation, in particular free radical/antioxidant homeostasis disturbances. The finding of relevant alterations of catalase, glutathione-transferase and peroxidase detoxifying activities significantly correlating with clinical manifestations of MCS, has recently registered some progress towards the identification of reliable biomarkers of disease onset, progression, and treatment outcomes.This publication has 138 references indexed in Scilit:
- Immunological aspects of chronic fatigue syndromeAutoimmunity Reviews, 2009
- AHR-mediated immunomodulation: The role of altered gene transcriptionBiochemical Pharmacology, 2009
- The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathwaysBiochemical Pharmacology, 2009
- General practitioners’ experiences with provision of healthcare to patients with self-reported multiple chemical sensitivityScandinavian Journal of Primary Health Care, 2009
- Oxidative stress in fibromyalgia and its relationship to symptomsClinical Rheumatology, 2008
- Biopsychosocial Influence on Exercise-induced Delayed Onset Muscle Soreness at the Shoulder: Pain Catastrophizing and Catechol-O-Methyltransferase (COMT) Diplotype Predict Pain RatingsThe Clinical Journal of Pain, 2008
- From evidence-based medicine to genomic medicineGenomic Medicine, 2007
- Peroxisomes and agingBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- The chemical defensome: Environmental sensing and response genes in the Strongylocentrotus purpuratus genomeDevelopmental Biology, 2006
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990